Serotonin genes and gene-gene interactions in borderline personality disorder in a matched case-control study

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 1, 2009, Pages 128-133

  Ni, Xingqun ^a   Chan, David ^a   Chan, Kirsten ^a   McMain, Shelley ^a   Kennedy, James L ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Association; Borderline personality disorder; Candidate gene; Gene gene interaction; Serotonin

Indexed keywords

SEROTONIN;

ADULT; ALLELE; ARTICLE; BORDERLINE STATE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAOA GENE; SEROTONIN 1A GENE; SEROTONIN 1B GENE; SEROTONIN 1D GENE; SEROTONIN 2A GENE; SEROTONIN 2C GENE; SEROTONIN 3A GENE; SEROTONIN GENE; SEROTONINERGIC SYSTEM; TPH1 GENE; TPH2 GENE;

ADULT; BORDERLINE PERSONALITY DISORDER; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MONOAMINE OXIDASE; POLYMORPHISM, GENETIC; RECEPTORS, SEROTONIN; SEROTONIN; TRYPTOPHAN HYDROXYLASE;

EID: 58149354209     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.10.022     Document Type: Article

References (66)

1. APA. Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association. Am J Psychiatry 158 (2001) 1-52
2. Arango V., Ernsberger P., Marzuk P.M., Chen J.S., Tierney H., and Stanley M. Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 47 (1990) 1038-1047
3. Audenaert K., Peremans K., Goethals I., Otte A., Dierckx R., and van Heeringen C. Functional imaging of the suicidal brain. Nucl Med Commun 26 (2005) 391-393
4. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
5. Berg K.A., Cropper J.D., Niswender C.M., Sanders-Bush E., Emeson R.B., and Clarke W.P. RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity. Br J Pharmacol 134 (2001) 386-392
6. Black D.W., Blum N., Pfohl B., and Hale N. Suicidal behavior in borderline personality disorder: prevalence, risk factors, prediction, and prevention. J Personal Disord 18 (2004) 226-239
7. Bland J.M., and Altman D.G. Statistics notes. The odds ratio. BMJ 320 (2000) 1468
8. Bondy B., Buettner A., and Zill P. Genetics of suicide. Mol Psychiatry 11 (2006) 336-351
9. Burns C.M., Chu H., Rueter S.M., Hutchinson L.K., Canton H., Sanders-Bush E., et al. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387 (1997) 303-308
10. Clarkin J.F., Widiger T.A., Frances A., Hurt S.W., and Gilmore M. Prototypic typology and the borderline personality disorder. J Abnorm Psychol 92 (1983) 263-275
11. Coccaro E.F., Kavoussi R.J., Oakes M., Cooper T.B., and Hauger R. 5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects. Psychopharmacology (Berl) 126 (1996) 24-30
12. Coccaro E.F., Kavoussi R.J., Sheline Y.I., Lish J.D., and Csernansky J.G. Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet. Arch Gen Psychiatry 53 (1996) 531-536
13. Courtet P., Jollant F., Castelnau D., Buresi C., and Malafosse A. Suicidal behavior: relationship between phenotype and serotonergic genotype. Am J Med Genet C Semin Med Genet 133 (2005) 25-33
14. de Almeida R.M., Giovenardi M., da Silva S.P., de Oliveira V.P., and Stein D.J. Maternal aggression in Wistar rats: effect of 5-HT2A/2C receptor agonist and antagonist microinjected into the dorsal periaqueductal gray matter and medial septum. Braz J Med Biol Res 38 (2005) 597-602
15. Dracheva S., Chin B., and Haroutunian V. Altered serotonin 2C receptor RNA splicing in suicide: association with editing. Neuroreport 19 (2008) 379-382
16. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Holt D., and Greer P.J. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46 (1999) 1375-1387
17. Driessen M., Herrmann J., Stahl K., Zwaan M., Meier S., and Hill A. Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization. Arch Gen Psychiatry 57 (2000) 1115-1122
18. Du L., Bakish D., Lapierre Y.D., Ravindran A.V., and Hrdina P.D. Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. Am J Med Genet 96 (2000) 56-60
19. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25 (2003) 115-121
20. Fentress H.M., Grinde E., Mazurkiewicz J.E., Backstrom J.R., Herrick-Davis K., and Sanders-Bush E. Pharmacological properties of the Cys23Ser single nucleotide polymorphism in human 5-HT2C receptor isoforms. Pharmacogenomics J 5 (2005) 244-254
21. Fletcher P.J., Tampakeras M., Sinyard J., and Higgins G.A. Opposing effects of 5-HT(2A) and 5-HT (2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test. Psychopharmacology (Berl) 195 (2007) 223-234
22. Friedel R.O. Dopamine dysfunction in borderline personality disorder: a hypothesis. Neuropsychopharmacology 29 (2004) 1029-1039
23. Gardner D.L., Lucas P.B., and Cowdry R.W. CSF metabolites in borderline personality disorder compared with normal controls. Biol Psychiatry 28 (1990) 247-254
24. Gauderman W.J., and Morrison J.M. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies (2006). http://hydrauscedu/gxe http://hydrauscedu/gxe
25. Giorgetti M., and Tecott L.H. Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems. Eur J Pharmacol 488 (2004) 1-9
26. Grosjean B., and Tsai G.E. NMDA neurotransmission as a critical mediator of borderline personality disorder. J Psychiatry Neurosci 32 (2007) 103-115
27. Gurevich I., Tamir H., Arango V., Dwork A.J., Mann J.J., and Schmauss C. Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 34 (2002) 349-356
28. Gutierrez B., Fananas L., Arranz M.J., Valles V., Guillamat R., van Os J., et al. Allelic association analysis of the 5-HT2C receptor gene in bipolar affective disorder. Neurosci Lett 212 (1996) 65-67
29. Hahn L.W., Ritchie M.D., and Moore J.H. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19 (2003) 376-382
30. Hansenne M., Pitchot W., Pinto E., Reggers J., Scantamburlo G., and Fuchs S. 5-HT1A dysfunction in borderline personality disorder. Psychol Med 32 (2002) 935-941
31. Klaassen T., Riedel W.J., van Praag H.M., Menheere P.P., and Griez E. Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression. Psychiatry Res 113 (2002) 29-40
32. Koenigsberg H.W., Harvey P.D., Mitropoulou V., Schmeidler J., New A.S., and Goodman M. Characterizing affective instability in borderline personality disorder. Am J Psychiatry 159 (2002) 784-788
33. Kulikov A.V., Osipova D.V., Naumenko V.S., and Popova N.K. Association between Tph2 gene polymorphism, brain tryptophan hydroxylase activity and aggressiveness in mouse strains. Genes Brain Behav 4 (2005) 482-485
34. Lappalainen J., Long J.C., Eggert M., Ozaki N., Robin R.W., and Brown G.L. Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations. Arch Gen Psychiatry 55 (1998) 989-994
35. Leyton M., Okazawa H., Diksic M., Paris J., Rosa P., and Mzengeza S. Brain Regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder. Am J Psychiatry 158 (2001) 775-782
36. Lieb K., Zanarini M.C., Schmahl C., Linehan M.M., and Bohus M. Borderline personality disorder. Lancet 364 (2004) 453-461
37. McKenzie-Quirk S.D., Girasa K.A., Allan A.M., and Miczek K.A. 5-HT(3) receptors, alcohol and aggressive behavior in mice. Behav Pharmacol 16 (2005) 163-169
38. Mitchell P.J., Fairhall S.J., Fletcher A., and Redfern P.H. Effects of single and repeated electroconvulsive shock on the social and agonistic behaviour of resident rats. Neuropharmacology 44 (2003) 911-925
39. Moeller F.G., Barratt E.S., Dougherty D.M., Schmitz J.M., and Swann A.C. Psychiatric aspects of impulsivity. Am J Psychiatry 158 (2001) 1783-1793
40. Moore J.H. A global view of epistasis. Nat Genet 37 (2005) 13-14
41. New A.S., Gelernter J., Yovell Y., Trestman R.L., Nielsen D.A., and Silverman J. Tryptophan hydroxylase genotype is associated with impulsive-aggression measures: a preliminary study. Am J Med Genet 81 (1998) 13-17
42. New A.S., Hazlett E.A., Buchsbaum M.S., Goodman M., Mitelman S.A., and Newmark R. Amygdala-prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology 32 (2007) 1629-1640
43. Ni X., Bismil R., Chan K., Sicard T., Bulgin N., and McMain S. Serotonin 2A receptor gene is associated with personality traits, but not to disorder, in patients with borderline personality disorder. Neurosci Lett 408 (2006) 214-219
44. Ni X., Chan K., Bulgin N., Sicard T., Bismil R., McMain S., et al. Association between serotonin transporter gene and borderline personality disorder. J Psychiatr Res 40 (2006) 448-453
45. Ni X., Sicard T., Bulgin N., Bismil R., Chan K., McMain S., et al. Monoamine oxidase a gene is associated with borderline personality disorder. Psychiatr Genet 17 (2007) 153-157
46. Nielsen D.A., Goldman D., Virkkunen M., Tokola R., Rawlings R., and Linnoila M. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch Gen Psychiatry 51 (1994) 34-38
47. Niswender C.M., Herrick-Davis K., Dilley G.E., Meltzer H.Y., Overholser J.C., and Stockmeier C.A. RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology 24 (2001) 478-491
48. O'Leary K.M., Brouwers P., Gardner D.L., and Cowdry R.W. Neuropsychological testing of patients with borderline personality disorder. Am J Psychiatry 148 (1991) 106-111
49. Okada M., Northup J.K., Ozaki N., Russell J.T., Linnoila M., and Goldman D. Modification of human 5-HT(2C) receptor function by Cys23Ser, an abundant, naturally occurring amino-acid substitution. Mol Psychiatry 9 (2004) 55-64
50. Pooley E.C., Houston K., Hawton K., and Harrison P.J. Deliberate self-harm is associated with allelic variation in the tryptophan hydroxylase gene (TPH A779C), but not with polymorphisms in five other serotonergic genes. Psychol Med 33 (2003) 775-783
51. Popova N.K. From genes to aggressive behavior: the role of serotonergic system. Bioessays 28 (2006) 495-503
52. Savitz J.B., Cupido C.L., and Ramesar R.S. Trends in suicidology: personality as an endophenotype for molecular genetic investigations. PLoS Med 3 (2006) e107
53. Schmahl C., and Bremner J.D. Neuroimaging in borderline personality disorder. J Psychiatr Res 40 (2006) 419-427
54. Simeon D., Stanley B., Frances A., Mann J.J., Winchel R., and Stanley M. Self-mutilation in personality disorders: psychological and biological correlates. Am J Psychiatry 149 (1992) 221-226
55. Skodol A.E., Gunderson J.G., Pfohl B., Widiger T.A., Livesley W.J., and Siever L.J. The borderline diagnosis I: psychopathology, comorbidity, and personality structure. Biol Psychiatry 51 (2002) 936-950
56. Skodol A.E., Siever L.J., Livesley W.J., Gunderson J.G., Pfohl B., and Widiger T.A. The borderline diagnosis II: biology, genetics, and clinical course. Biol Psychiatry 51 (2002) 951-963
57. Soloff P.H., Meltzer C.C., Greer P.J., Constantine D., and Kelly T.M. A fenfluramine-activated FDG-PET study of borderline personality disorder. Biol Psychiatry 47 (2000) 540-547
58. Souery D., Van Gestel S., Massat I., Blairy S., Adolfsson R., and Blackwood D. Tryptophan hydroxylase polymorphism and suicidality in unipolar and bipolar affective disorders: a multicenter association study. Biol Psychiatry 49 (2001) 405-409
59. Stefulj J., Buttner A., Kubat M., Zill P., Balija M., and Eisenmenger W. 5HT-2C receptor polymorphism in suicide victims. Association studies in German and Slavic populations. Eur Arch Psychiatry Clin Neurosci 254 (2004) 224-227
60. Strauss J., Barr C.L., George C.J., King N., Shaikh S., and Devlin B. Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder. Am J Med Genet B Neuropsychiatr Genet 131B (2004) 16-19
61. Walter M., Bureau J.F., Holmes B.M., Bertha E.A., Hollander M., and Wheelis J. Cortisol response to interpersonal stress in young adults with borderline personality disorder: a pilot study. Eur Psychiatry 23 (2008) 201-204
62. Walther D.J., Peter J.U., Bashammakh S., Hortnagl H., Voits M., and Fink H. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299 (2003) 76
63. Wasserman D., Geijer T., Sokolowski M., Rozanov V., and Wasserman J. The serotonin 1A receptor C(-1019)G polymorphism in relation to suicide attempt. Behav Brain Funct 2 (2006) 14
64. Winstanley C.A., Theobald D.E., Dalley J.W., Glennon J.C., and Robbins T.W. 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology (Berl) 176 (2004) 376-385
65. Zhou Z., Roy A., Lipsky R., Kuchipudi K., Zhu G., and Taubman J. Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations. Arch Gen Psychiatry 62 (2005) 1109-1118
66. Zill P., Buttner A., Eisenmenger W., Moller H.J., Bondy B., and Ackenheil M. Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biol Psychiatry 56 (2004) 581-586